Merck To Conduct Drug Research On ISS

Credit: Credit: NASA
Pending final approval from the Center for the Advancement of Science in Space (Casis), Merck Research Laboratories will begin studying therapeutic monoclonal antibodies (MABs) on the International Space Station to learn if the microgravity environment there can aid in drug development. Casis, the...

Subscription Required


This content requires a subscription to one of the Aviation Week Intelligence Network (AWIN) bundles.

Schedule a demo today to find out how you can access this content and similar content related to your area of the global aviation industry.

Already an AWIN subscriber? Login


Did you know?  Aviation Week has won top honors multiple times in the Jesse H. Neal National Business Journalism Awards, the business-to-business media equivalent of the Pulitzer Prizes.